GEODE CAPITAL MANAGEMENT, LLC - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$40,741,233
+85.5%
1,060,417
+11.8%
0.01%
+66.7%
Q1 2023$21,958,963
+91579.0%
948,551
+3.8%
0.00%0.0%
Q4 2022$23,952
-99.9%
914,226
+4.5%
0.00%0.0%
Q3 2022$17,193,000
+18.4%
874,557
+5.4%
0.00%
+50.0%
Q2 2022$14,517,000
+14.2%
830,074
+6.8%
0.00%0.0%
Q1 2022$12,712,000
+6.2%
777,066
+5.9%
0.00%
+100.0%
Q4 2021$11,965,000
+51.3%
733,657
+18.4%
0.00%0.0%
Q3 2021$7,908,000
-9.5%
619,769
+0.2%
0.00%0.0%
Q2 2021$8,736,000
+26.0%
618,706
+38.7%
0.00%0.0%
Q1 2021$6,931,000
+6.5%
446,037
+8.7%
0.00%0.0%
Q4 2020$6,506,000410,2200.00%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Parallel Advisors, LLC 5$00.00%
View complete list of CHINOOK THERAPEUTICS INC shareholders